{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:47:59Z","timestamp":1777337279143,"version":"3.51.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70669-9","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:53:42Z","timestamp":1773309222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PTBP1 inhibition reprograms myogenesis to rescue impaired muscle regeneration in mdx mice through correcting E2A splicing"],"prefix":"10.1038","volume":"17","author":[{"given":"Shusheng","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haowei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoqiao","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huitao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0420-0822","authenticated-orcid":false,"given":"Zhenzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"70669_CR1","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41586-024-08310-2","volume":"637","author":"L Wan","year":"2025","unstructured":"Wan, L. et al. Structure and assembly of the dystrophin glycoprotein complex. Nature. 637, 1252\u20131260 (2025).","journal-title":"Nature"},{"key":"70669_CR2","doi-asserted-by":"publisher","first-page":"dmm043638","DOI":"10.1242\/dmm.043638","volume":"13","author":"MD Grounds","year":"2020","unstructured":"Grounds, M. D. et al. Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. Dis. Model Mech. 13, dmm043638 (2020).","journal-title":"Dis. Model Mech."},{"key":"70669_CR3","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof, B. J. et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. PNAS 90, 3710\u20133714 (1993).","journal-title":"PNAS"},{"key":"70669_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"S Crisafulli","year":"2020","unstructured":"Crisafulli, S. et al. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J. Rare Dis. 15, 141 (2020).","journal-title":"Orphanet J. Rare Dis."},{"key":"70669_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder, S. et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J. Rare Dis. 12, 79 (2017).","journal-title":"Orphanet J. Rare Dis."},{"key":"70669_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen, C. L. et al. The TREAT-NMD DMD Global Database: analysis of more than 7000 Duchenne muscular dystrophy mutations. Hum. Mutat. 36, 395\u2013402 (2015).","journal-title":"Hum. Mutat."},{"key":"70669_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.nmd.2021.08.004","volume":"31","author":"F Fortunato","year":"2021","unstructured":"Fortunato, F. et al. The DMD gene and therapeutic approaches to restore dystrophin. Neuromuscular Disord. 31, 1013\u20131020 (2021).","journal-title":"Neuromuscular Disord."},{"key":"70669_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41573-023-00775-6","volume":"22","author":"TC Roberts","year":"2023","unstructured":"Roberts, T. C. et al. Therapeutic approaches for Duchenne muscular dystrophy. Nat. Rev. Nat. Rev. Drug Discov. 22, 917\u2013934 (2023).","journal-title":"Nat. Rev. Nat. Rev. Drug Discov."},{"key":"70669_CR9","volume":"2016","author":"E Matthews","year":"2016","unstructured":"Matthews, E. et al. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst. Rev. 2016, CD003725 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"70669_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 17, 347\u2013361 (2018).","journal-title":"Lancet Neurol."},{"key":"70669_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207948","volume":"102","author":"E Landfeldt","year":"2024","unstructured":"Landfeldt, E. et al. Bisphosphonates in glucocorticoid-treated patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence. Neurology. 102, e207948 (2024).","journal-title":"Neurology"},{"key":"70669_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1183101","volume":"14","author":"A Bez Batti Angulski","year":"2023","unstructured":"Bez Batti Angulski, A. et al. Duchenne Muscular Dystrophy: disease mechanism and therapeutic strategies. Front. Physiol. 14, 1183101 (2023).","journal-title":"Front. Physiol."},{"key":"70669_CR13","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1152\/japplphysiol.00379.2018","volume":"125","author":"KM Virgilio","year":"2018","unstructured":"Virgilio, K. M. et al. Agent-based model illustrates the role of the microenvironment in regeneration in healthy and mdx skeletal muscle. J. Appl. Physiol. 125, 1424\u20131439 (2018).","journal-title":"J. Appl. Physiol."},{"key":"70669_CR14","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/febs.14417","volume":"285","author":"LA Perandini","year":"2018","unstructured":"Perandini, L. A. et al. Chronic inflammation in skeletal muscle impairs satellite cells function during regeneration: can physical exercise restore the satellite cell niche? FEBS J. 285, 1973\u20131984 (2018).","journal-title":"FEBS J."},{"key":"70669_CR15","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.4049\/jimmunol.1103180","volume":"189","author":"B Deng","year":"2012","unstructured":"Deng, B. et al. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J. Immunol. 189, 3669\u20133680 (2012).","journal-title":"J. Immunol."},{"key":"70669_CR16","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1007\/s00415-023-11796-x","volume":"270","author":"M Chang","year":"2023","unstructured":"Chang, M. et al. Duchenne muscular dystrophy: pathogenesis and promising therapies. J. Neurol. 270, 3733\u20133749 (2023).","journal-title":"J. Neurol."},{"key":"70669_CR17","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.3390\/ijms251910393","volume":"25","author":"F Hernandez-Torres","year":"2024","unstructured":"Hernandez-Torres, F. et al. Macrophages in the context of muscle regeneration and duchenne muscular dystrophy. Int. J. Mol. Sci. 25, 10393 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"70669_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1159\/000514305","volume":"211","author":"RL Filippelli","year":"2022","unstructured":"Filippelli, R. L. & Chang, N. C. Empowering muscle stem cells for the treatment of duchenne muscular dystrophy. Cells Tissues Organs. 211, 641\u2013654 (2022).","journal-title":"Cells Tissues Organs"},{"key":"70669_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/965631","volume":"2014","author":"Y Kharraz","year":"2014","unstructured":"Kharraz, Y. et al. Understanding the process of fibrosis in Duchenne muscular dystrophy. Biomed. Res. Int. 2014, 965631 (2014).","journal-title":"Biomed. Res. Int."},{"key":"70669_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-1-21","volume":"1","author":"CJ Mann","year":"2011","unstructured":"Mann, C. J. et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle. 1, 21 (2011).","journal-title":"Skelet. Muscle"},{"key":"70669_CR21","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1073\/pnas.0808866106","volume":"106","author":"CL Semerad","year":"2009","unstructured":"Semerad, C. L. et al. E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors. PNAS. 106, 1930\u20131935 (2009).","journal-title":"PNAS"},{"key":"70669_CR22","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.15252\/embj.201591118","volume":"34","author":"C Bohrer","year":"2015","unstructured":"Bohrer, C. et al. The balance of Id3 and E47 determines neural stem\/precursor cell differentiation into astrocytes. EMBO J. 34, 2804\u20132819 (2015).","journal-title":"EMBO J."},{"key":"70669_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1101\/gad.1765109","volume":"23","author":"Z Yang","year":"2009","unstructured":"Yang, Z. et al. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state. Genes. Dev. 23, 694\u2013707 (2009).","journal-title":"Genes. Dev."},{"key":"70669_CR24","first-page":"15","volume":"28","author":"JJ Liang","year":"2021","unstructured":"Liang, J. J. et al. Relationship between the structure and function of the transcriptional regulator E2A. J. Biol. Res. 28, 15 (2021).","journal-title":"J. Biol. Res."},{"key":"70669_CR25","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1101\/gad.316984.118","volume":"32","author":"T Yamazaki","year":"2018","unstructured":"Yamazaki, T. et al. TCF3 alternative splicing controlled by hnRNP H\/F regulates E-cadherin expression and hESC pluripotency. Genes. Dev. 32, 1161\u20131174 (2018).","journal-title":"Genes. Dev."},{"key":"70669_CR26","first-page":"3917","volume":"144","author":"S Pfurr","year":"2017","unstructured":"Pfurr, S. et al. The E2A splice variant E47 regulates the differentiation of projection neurons via p57(KIP2) during cortical development. Development. 144, 3917\u20133931 (2017).","journal-title":"Development"},{"key":"70669_CR27","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20090756","volume":"206","author":"K Beck","year":"2009","unstructured":"Beck, K., Peak, M. M., Ota, T., Nemazee, D. & Murre, C. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J. Exp. Med. 206, 2271\u20132284 (2009).","journal-title":"J. Exp. Med."},{"key":"70669_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0002-9440(10)65557-5","volume":"153","author":"MN Rutherford","year":"1998","unstructured":"Rutherford, M. N. & LeBrun, D. P. Restricted expression of E2A protein in primary human tissues correlates with proliferation and differentiation. Am. J. Pathol. 153, 165\u2013173 (1998).","journal-title":"Am. J. Pathol."},{"key":"70669_CR29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1261\/rna.072298.119","volume":"25","author":"T Yamazaki","year":"2019","unstructured":"Yamazaki, T., Liu, L. & Manley, J. L. TCF3 mutually exclusive alternative splicing is controlled by long-range cooperative actions between hnRNPH1 and PTBP1. RNA. 25, 1497\u20131508 (2019).","journal-title":"RNA"},{"key":"70669_CR30","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1080\/15476286.2020.1772559","volume":"17","author":"T Yamazaki","year":"2020","unstructured":"Yamazaki, T., Liu, L., Conlon, E. G. & Manley, J. L. Burkitt lymphoma-related TCF3 mutations alter TCF3 alternative splicing by disrupting hnRNPH1 binding. RNA Biol. 17, 1383\u20131390 (2020).","journal-title":"RNA Biol."},{"key":"70669_CR31","doi-asserted-by":"publisher","first-page":"e09268","DOI":"10.7554\/eLife.09268","volume":"4","author":"AJ Linares","year":"2015","unstructured":"Linares, A. J. et al. The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation. ELife. 4, e09268 (2015).","journal-title":"ELife"},{"key":"70669_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13046-023-02827-6","volume":"42","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement. J. Exp. Clin. Cancer Res. 42, 246 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"70669_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.stem.2024.04.001","volume":"31","author":"M Nazim","year":"2024","unstructured":"Nazim, M. et al. Alternative splicing of a chromatin modifier alters the transcriptional regulatory programs of stem cell maintenance and neuronal differentiation. Cell Stem Cell. 31, 754\u2013771.e6 (2024).","journal-title":"Cell Stem Cell"},{"key":"70669_CR34","first-page":"e489","volume":"277","author":"DN Proctor","year":"1999","unstructured":"Proctor, D. N., O\u2019Brien, P. C., Atkinson, E. J. & Nair, K. S. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am. J. Physiol. 277, e489\u2013e495 (1999).","journal-title":"Am. J. Physiol."},{"key":"70669_CR35","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/embor.2013.182","volume":"14","author":"CF Bentzinger","year":"2013","unstructured":"Bentzinger, C. F., Wang, Y. X., Dumont, N. A. & Rudnicki, M. A. Cellular dynamics in the muscle satellite cell niche. EMBO Rep. 14, 1062\u20131072 (2013).","journal-title":"EMBO Rep."},{"key":"70669_CR36","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/j.2040-4603.2015.tb00646.x","volume":"5","author":"NA Dumont","year":"2015","unstructured":"Dumont, N. A., Bentzinger, C. F., Sincennes, M. C. & Rudnicki, M. A. Satellite cells and skeletal muscle regeneration. Compr. Physiol. 5, 1027\u20131059 (2015).","journal-title":"Compr. Physiol."},{"key":"70669_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0092-8674(89)90682-X","volume":"56","author":"C Murre","year":"1989","unstructured":"Murre, C., McCaw, P. S. & Baltimore, D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell. 56, 777\u2013783 (1989).","journal-title":"Cell"},{"key":"70669_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0092-8674(91)90653-G","volume":"64","author":"XH Sun","year":"1991","unstructured":"Sun, X. H. & Baltimore, D. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell. 64, 459\u2013470 (1991).","journal-title":"Cell"},{"key":"70669_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0092-8674(91)90620-E","volume":"66","author":"AB Lassar","year":"1991","unstructured":"Lassar, A. B. et al. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12\/E47-like proteins in vivo. Cell. 66, 305\u2013315 (1991).","journal-title":"Cell"},{"key":"70669_CR40","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1021\/bi970262m","volume":"36","author":"SJ Maleki","year":"1997","unstructured":"Maleki, S. J., Royer, C. A. & Hurlburt, B. K. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable. Biochemistry. 36, 6762\u20136767 (1997).","journal-title":"Biochemistry"},{"key":"70669_CR41","doi-asserted-by":"publisher","first-page":"119506","DOI":"10.1016\/j.bbamcr.2023.119506","volume":"1870","author":"HL Liu","year":"2023","unstructured":"Liu, H. L. et al. The role of RNA splicing factor PTBP1 in neuronal development. Biochim. Biophys. Acta Mol. Cell Res. 1870, 119506 (2023).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"70669_CR42","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s11010-023-04905-x","volume":"479","author":"Q Yu","year":"2024","unstructured":"Yu, Q. et al. PTBP1 as a potential regulator of disease. Mol. Cell Biochem. 479, 2875\u20132894 (2024).","journal-title":"Mol. Cell Biochem."},{"key":"70669_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70675","volume":"29","author":"C Ji","year":"2025","unstructured":"Ji, C. et al. PTBP1 and cancer: from RNA regulation to therapeutic potential. J. Cell Mol. Med. 29, e70675 (2025).","journal-title":"J. Cell Mol. Med."},{"key":"70669_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/genes11040402","volume":"11","author":"SL Fochi","year":"2020","unstructured":"Fochi, S. L. et al. The emerging role of the RBM20 and PTBP1 ribonucleoproteins in heart development and cardiovascular diseases. Genes. 11, 402 (2020).","journal-title":"Genes"},{"key":"70669_CR45","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/jcp.30716","volume":"237","author":"S Dai","year":"2022","unstructured":"Dai, S. et al. PTB: Not just a polypyrimidine tract-binding protein. J. Cell Physiol. 237, 2357\u20132373 (2022).","journal-title":"J. Cell Physiol."},{"key":"70669_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1101\/gad.1500707","volume":"21","author":"PL Boutz","year":"2007","unstructured":"Boutz, P. L., Chawla, G., Stoilov, P. & Black, D. L. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev. 21, 71\u201384 (2007).","journal-title":"Genes Dev."},{"key":"70669_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.molcel.2007.06.016","volume":"27","author":"R Spellman","year":"2007","unstructured":"Spellman, R., Llorian, M. & Smith, C. W. Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol. Cell. 27, 420\u2013434 (2007).","journal-title":"Mol. Cell"},{"key":"70669_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2015.03.026","volume":"363","author":"K Taniguchi","year":"2015","unstructured":"Taniguchi, K. et al. MicroRNA-124 inhibits cancer cell growth through PTB1\/PKM1\/PKM2 feedback cascade in colorectal cancer. Cancer Lett. 363, 17\u201327 (2015).","journal-title":"Cancer Lett."},{"key":"70669_CR49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400784R","volume":"38","author":"M Olea-Flores","year":"2024","unstructured":"Olea-Flores, M. et al. Muscle-specific pyruvate kinase isoforms, PKM1 and PKM2, regulate mammalian SWI\/SNF proteins and histone 3 phosphorylation during myoblast differentiation. FASEB J. 38, e23702 (2024).","journal-title":"FASEB J."},{"key":"70669_CR50","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.1128\/MCB.00893-06","volume":"26","author":"J Sauli\u00e8re","year":"2006","unstructured":"Sauli\u00e8re, J., Sureau, A., Expert-Bezan\u00e7on, A. & Marie, J. The polypyrimidine tract binding protein (PTB) represses splicing of exon 6B from the beta-tropomyosin pre-mRNA by directly interfering with the binding of the U2AF65 subunit. Mol. Cell Biol. 26, 8755\u20138769 (2006).","journal-title":"Mol. Cell Biol."},{"key":"70669_CR51","doi-asserted-by":"publisher","first-page":"25480","DOI":"10.1016\/S0021-9258(19)74066-6","volume":"267","author":"GJ Mulligan","year":"1992","unstructured":"Mulligan, G. J., Guo, W., Wormsley, S. & Helfman, D. M. Polypyrimidine tract binding protein interacts with sequences involved in alternative splicing of beta-tropomyosin pre-mRNA. J. Biol. Chem. 267, 25480\u201325487 (1992).","journal-title":"J. Biol. Chem."},{"key":"70669_CR52","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1261\/rna.038422.113","volume":"19","author":"MP Hall","year":"2013","unstructured":"Hall, M. P. et al. Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. RNA. 19, 627\u2013638 (2013).","journal-title":"RNA"},{"key":"70669_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1242\/dmm.018424","volume":"8","author":"JW McGreevy","year":"2015","unstructured":"McGreevy, J. W., Hakim, C. H., McIntosh, M. A. & Duan, D. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis. Model Mech. 8, 195\u2013213 (2015).","journal-title":"Dis. Model Mech."},{"key":"70669_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-017-0139-5","volume":"7","author":"TL Kennedy","year":"2017","unstructured":"Kennedy, T. L. et al. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle. Skelet. Muscle. 7, 22 (2017).","journal-title":"Skelet. Muscle"},{"key":"70669_CR55","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.121.054628","volume":"144","author":"J Li","year":"2021","unstructured":"Li, J. et al. Therapeutic exon skipping through a CRISPR-guided cytidine deaminase rescues dystrophic cardiomyopathy in vivo. Circulation. 144, 1760\u20131776 (2021).","journal-title":"Circulation"},{"key":"70669_CR56","doi-asserted-by":"publisher","first-page":"1094359","DOI":"10.3389\/fphys.2023.1094359","volume":"14","author":"M Sato","year":"2023","unstructured":"Sato, M., Goto, M., Yamanouchi, K. & Sakurai, H. A new immunodeficient Duchenne muscular dystrophy rat model to evaluate engraftment after human cell transplantation. Front. Physiol. 14, 1094359 (2023).","journal-title":"Front. Physiol."},{"key":"70669_CR57","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1016\/j.cell.2024.08.041","volume":"187","author":"S Ren","year":"2024","unstructured":"Ren, S. et al. Profound cellular defects attribute to muscular pathogenesis in the rhesus monkey model of Duchenne muscular dystrophy. Cell. 187, 6669\u20136686 (2024).","journal-title":"Cell"},{"key":"70669_CR58","doi-asserted-by":"publisher","first-page":"167011","DOI":"10.1016\/j.bbadis.2023.167011","volume":"1870","author":"S Gao","year":"2024","unstructured":"Gao, S., Wang, Y., Xu, Y., Liu, L. & Liu, S. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis. Biochim. Biophys. Acta. Mol. Basis. Dis. 1870, 167011 (2024).","journal-title":"Biochim. Biophys. Acta. Mol. Basis. Dis."},{"key":"70669_CR59","doi-asserted-by":"publisher","first-page":"174837","DOI":"10.1016\/j.ejphar.2022.174837","volume":"920","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: Involvement of PTBP1\/PKM1\/2 pathway. Eur. J. Pharmacol. 920, 174837 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"70669_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25892-x","volume":"12","author":"JH Kim","year":"2021","unstructured":"Kim, J. H. et al. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1\/PTBP2 switching and RBFOX2 activity. Nat. Commun. 12, 5551 (2021).","journal-title":"Nat. Commun."},{"key":"70669_CR61","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.molmed.2017.09.002","volume":"23","author":"AML Coenen-Stass","year":"2017","unstructured":"Coenen-Stass, A. M. L., Wood, M. J. A. & Roberts, T. C. Biomarker potential of extracellular miRNAs in Duchenne Muscular Dystrophy. Trends Mol. Med. 23, 989\u20131001 (2017).","journal-title":"Trends Mol. Med."},{"key":"70669_CR62","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/emmm.201100133","volume":"3","author":"D Cacchiarelli","year":"2011","unstructured":"Cacchiarelli, D. et al. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol. Med. 3, 258\u2013265 (2011).","journal-title":"EMBO Mol. Med."},{"key":"70669_CR63","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1261\/rna.078993.121","volume":"28","author":"ER Hinkle","year":"2022","unstructured":"Hinkle, E. R. et al. Alternative splicing regulation of membrane trafficking genes during myogenesis. RNA. 28, 523\u2013540 (2022).","journal-title":"RNA"},{"key":"70669_CR64","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1042\/BST20160080","volume":"44","author":"MB Coelho","year":"2016","unstructured":"Coelho, M. B. et al. Functional interactions between polypyrimidine tract binding protein and PRI peptide ligand containing proteins. Biochem. Soc. Trans. 44, 1058\u20131065 (2016).","journal-title":"Biochem. Soc. Trans."},{"key":"70669_CR65","doi-asserted-by":"publisher","first-page":"14038","DOI":"10.1038\/mtm.2014.38","volume":"1","author":"AL Arnett","year":"2014","unstructured":"Arnett, A. L. et al. Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells. Mol. Ther. Methods Clin. Dev. 1, 14038 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"70669_CR66","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.omtm.2020.09.016","volume":"19","author":"JB Kwon","year":"2020","unstructured":"Kwon, J. B. et al. In vivo gene editing of muscle stem cells with adeno-associated viral vectors in a mouse model of Duchenne Muscular Dystrophy. Mol. Ther. Methods Clin. Dev. 19, 320\u2013329 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"70669_CR67","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.ymthe.2019.06.012","volume":"27","author":"ME Nance","year":"2019","unstructured":"Nance, M. E. et al. AAV9 edits muscle stem cells in normal and dystrophic adult mice. Mol. Ther. 27, 1568\u20131585 (2019).","journal-title":"Mol. Ther."},{"key":"70669_CR68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar, M. et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science. 351, 407\u2013411 (2016).","journal-title":"Science"},{"key":"70669_CR69","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41417-020-0178-7","volume":"27","author":"S Weng","year":"2020","unstructured":"Weng, S. et al. Improvement of muscular atrophy by AAV-SaCas9-mediated myostatin gene editing in aged mice. Cancer Gene Ther. 27, 960\u2013975 (2020).","journal-title":"Cancer Gene Ther."},{"key":"70669_CR70","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/nprot.2015.110","volume":"10","author":"L Liu","year":"2015","unstructured":"Liu, L., Cheung, T. H., Charville, G. W. & Rando, T. A. Isolation of skeletal muscle stem cells by fluorescence-activated cell sorting. Nat. Protoc. 10, 1612\u20131624 (2015).","journal-title":"Nat. Protoc."},{"key":"70669_CR71","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.celrep.2017.10.037","volume":"21","author":"CTJ van Velthoven","year":"2017","unstructured":"van Velthoven, C. T. J., de Morree, A., Egner, I. M., Brett, J. O. & Rando, T. A. Transcriptional profiling of quiescent muscle stem cells in vivo. Cell Rep. 21, 1994\u20132004 (2017).","journal-title":"Cell Rep."},{"key":"70669_CR72","doi-asserted-by":"publisher","first-page":"689533","DOI":"10.3389\/fcell.2021.689533","volume":"9","author":"S Yao","year":"2021","unstructured":"Yao, S. et al. Current pharmacological strategies for Duchenne muscular dystrophy. Front. Cell. Dev. Biol. 9, 689533 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"70669_CR73","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40265-024-02052-1","volume":"84","author":"YN Lamb","year":"2024","unstructured":"Lamb, Y. N. Givinostat: first approval. Drugs 84, 849\u2013856 (2024).","journal-title":"Drugs"},{"key":"70669_CR74","doi-asserted-by":"publisher","first-page":"175277","DOI":"10.1016\/j.ejphar.2022.175277","volume":"933","author":"S Fan","year":"2022","unstructured":"Fan, S. et al. p-TAK1 acts as a switch between myoblast proliferation phase and differentiation phase in mdx mice via regulating HO-1 expression. Eur. J. Pharmacol. 933, 175277 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"70669_CR75","first-page":"51303","volume":"85","author":"A Aartsma-Rus","year":"2014","unstructured":"Aartsma-Rus, A. & van Putten, M. Assessing functional performance in the mdx mouse model. J. Vis. Exp. 85, 51303 (2014).","journal-title":"J. Vis. Exp."},{"key":"70669_CR76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jcsm.12650","volume":"12","author":"D Xu","year":"2021","unstructured":"Xu, D. et al. TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy. J. Cachexia Sarcopenia Muscle. 12, 192\u2013208 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70669-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70669-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70669-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:03:17Z","timestamp":1777334597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70669-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70669"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70669-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3838"}}